Connect with us
GigaGen will develop a recombinant polyclonal antibody therapy for botulinum neurotoxins and another biological threat. Grifols expects €930 million in U.S. revenues from Yimmugo, an immunoglobulin...
Quadrato, a 16th-century luxury building in Turin's Roman Quadrilateral, has been restored, revealing archaeological finds. Gruppo Building and Concrete Investing offer an investment opportunity in two...
IOTA plans to make an announcement on October 15, but skepticism surrounds it, as past promises like IOTA Qubic never materialized. Concerns linger over delays in...
Original Gangster Deluxe is a strain that stands out from other medical marijuana products available in Poland. With a high THC concentration of 25%, a rich...
Voilàp is advancing its carbon reduction efforts by using carbon-neutral steel for its subsidiary Imecon, replacing 150 tons annually. The plan will expand to other group...
Alfasigma has acquired the marketing rights for Jyseleca, a JAK1 inhibitor drug used for rheumatoid arthritis and ulcerative colitis, following European Medicines Agency approval. This acquisition...
The Detmold district approved North Rhine-Westphalia’s first cannabis cultivation association, "Joints Venture," which began cultivation immediately. With 500 members, the association expects its first harvest by...
CrowdFundMe achieved positive EBITDA of €57,000 in the first half of 2024, compared to a loss of €77,000 in 2023, driven by its real estate lending...
Despite challenging market conditions, Moneyfarm has experienced strong growth, with assets increasing by 51% and clients by 23%, reaching 5 billion euros and over 130,000 clients....
Ripple is awaiting the SEC's decision on whether to appeal the XRP court ruling by October 7. Meanwhile, Ripple has secured regulatory approval in Dubai to...